Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 11/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.35 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
| ▸ | BTK | Q06187 | 1/20 | 0.33 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.33 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30396230 | 1.00 | HSD11B1 (0.37) | HSD11B1ADORA3NR1I2BTKTNK2 | |
| SCHEMBL21138249 | 0.87 | HSD11B1 (0.45) | HSD11B1ADORA3NR1I2TNK2CCNE1 | |
| SCHEMBL21138331 | 0.86 | HSD11B1 (0.47) | HSD11B1ADORA3NR1I2CCNE1CDK2 | |
| SCHEMBL25525429 | 0.85 | HSD11B1 (0.34) | HSD11B1ADORA3NR1I2BTKTNK2 | |
| SCHEMBL21138816 | 0.84 | HSD11B1 (0.49) | HSD11B1ADORA3NR1I2CCNE1CDK2 | |
| SCHEMBL21057446 | 0.84 | HSD11B1 (0.37) | HSD11B1ADORA3NR1I2CCNE1CDK2 | |
| SCHEMBL19917049 | 0.84 | HSD11B1 (0.37) | HSD11B1ADORA3NR1I2CCNE1CDK2 | |
| SCHEMBL21138374 | 0.81 | HSD11B1 (0.35) | HSD11B1ADORA3NR1I2TNK2 | |
| SCHEMBL21159124 | 0.80 | HSD11B1 (0.37) | HSD11B1ADORA3NR1I2CCNE1CDK2 | |
| SCHEMBL21159625 | 0.80 | HSD11B1 (0.33) | HSD11B1ADORA3NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023091726-A1 | INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) | SYROS PHARMACEUTICALS, INC. (US) | 2023-05-25 | — | — | WO | disclosed |